| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J1428 |
Injection, eteplirsen, 10 mg |
4,411 |
915 |
$92.29M |
| J1426 |
Injection, casimersen, 10 mg |
2,062 |
747 |
$65.64M |
| J0584 |
Injection, burosumab-twza 1 mg |
510 |
320 |
$9.85M |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
7,728 |
6,913 |
$9.20M |
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
3,261 |
2,505 |
$4.69M |
| Q9991 |
Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
2,657 |
2,022 |
$3.72M |
| J3490 |
Unclassified drugs |
26 |
14 |
$921K |
| 99602 |
Nursing care in home rn |
2,343 |
659 |
$428K |
| 99601 |
|
4,040 |
1,259 |
$413K |
| S9379 |
Home infusion therapy, infusion therapy, not otherwise classified; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
2,331 |
784 |
$186K |
| J3032 |
Injection, eptinezumab-jjmr, 1 mg |
57 |
56 |
$123K |
| A4222 |
Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately) |
313 |
92 |
$7K |